中国组织工程研究

• 材料生物相容性 material biocompatibility • 上一篇    下一篇

骨形态发生蛋白2/注射式硫酸钙缓释载体的生物相容性

陈  琛1,徐晓峰2   

  1. 1铜陵市人民医院,安徽省铜陵市  244000
    2江苏大学附属医院骨科,江苏省镇江市  212001
  • 收稿日期:2012-08-06 修回日期:2013-03-24 出版日期:2013-05-21 发布日期:2013-05-21
  • 通讯作者: 徐晓峰,主任医师,江苏大学附属医院骨科,江苏省镇江市 212001 13775534791@163.com
  • 作者简介:陈琛★,1987年生,安徽省芜湖市人,汉族,2012年江苏大学毕业,硕士,医师,主要从事骨组织工程方面的研究。 cicichan1987@163.com
  • 基金资助:

    镇江市社会发展基金资助项目(SH2002019),课题名称:骨髓间质干细胞体外扩增回植对骨缺损的作用。

Biocompatibility of bone morphogenetic protein-2/injectable calcium sulfate cement slow-release carriers

Chen Chen1, Xu Xiao-feng2   

  1. 1 Tongling People’s Hospital, Tongling  244000, Anhui Province, China
    2 Department of Orthopedics, Affiliated Hospital of Jiangsu University, Zhenjiang  2120001, Jiangsu Province, China
  • Received:2012-08-06 Revised:2013-03-24 Online:2013-05-21 Published:2013-05-21
  • Contact: Xu Xiao-feng, Chief physician, Tongling People’s Hospital, Department of Orthopedics, Affiliated Hospital of Jiangsu University, Zhenjiang 2120001, Jiangsu Province, China 13775534791@163.com
  • About author:Chen Chen★, Master, Physician, Tongling People’s Hospital, Tongling 244000, Anhui Province, China cicichan1987@163.com
  • Supported by:

    the Social Development Fund Project of Zhenjiang City, No. SH2002019

摘要:

背景:目前硫酸钙主要被作为抗生素载体和成骨因子载体。
目的:观察骨形态发生蛋白2/注射式硫酸钙缓释系统的体外缓释效果及与种子细胞的生物相容性。
方法:制备骨形态发生蛋白2/注射式硫酸钙缓释系统,检测其体外释放性能。将SD大鼠骨髓间充质干细胞经体外诱导培养、扩增后,种植于骨形态发生蛋白2/注射式硫酸钙缓释载体和单纯的注射式硫酸钙支架上行体外培养。
结果与结论:骨形态发生蛋白2/注射式硫酸钙缓释支架具有缓释骨形态发生蛋白2的效果,持续时间可达31 d。骨形态发生蛋白2/注射式硫酸钙缓释支架与大鼠骨髓间充质干细胞具有优良的生物相容性,并且相同时间点支架上的细胞黏附率、细胞数量及细胞碱性磷酸酶活性均明显高于注射式硫酸钙支架;扫描电镜发现两组材料上均有细胞生长,骨形态发生蛋白2/注射式硫酸钙缓释支架上的细胞在支架表面和孔隙内生长良好,细胞突起接触融合,细胞密集区域可见细胞外基质形成,大量细胞包绕在材料表面;注射式硫酸钙支架上的细胞黏附数量较少,生长情况不及骨形态发生蛋白2/注射式硫酸钙缓释支架上的细胞。

关键词: 生物材料, 材料生物相容性, 骨形态发生蛋白2, 注射式硫酸钙, 大鼠骨髓间充质干细胞, 生物相容性, 其他基金

Abstract:

BACKGROUND: The calcium sulfate is mostly used as carriers for antibiotics and osteogenic factors by now. 
OBJECTIVE: To observe the in vitro delivery effect of bone morphogenetic protein-2/injectable calcium sulfate cement slow-release system and the in vitro biocompatibility with bone marrow mesenchymal stem cells.
METHODS: Bone morphogenetic protein-2/injectable calcium sulfate cement slow-release scaffold was prepared and its release properties were detected. Bone marrow mesenchymal stem cells obtained from Sprague-Dawley rats were induced, cultured and proliferated in vitro, and then, the cells were seeded onto the bone morphogenetic protein-2/injectable calcium sulfate cement scaffolds (experimental group) or single injectable calcium sulfate cement scaffolds (control group).
RESULTS AND CONCLUSION: The release of bone morphogenetic protein-2 on the scaffolds of experimental group could last for 31 days. Rat bone marrow mesenchymal stem cells had a good biocompatibility with the bone morphogenetic protein-2/injectable calcium sulfate cement scaffolds. The adhesive rate, cell number and alkaline phosphatase activity at the same time point in the scaffolds of experimental group were significantly greater than those of the control group. Cells could be observed on each scaffold under a scanning electron microscope. In the experimental group, interconnected cell processes were fused, extracellular matrix was visible in the dense area, and the scaffold was surrounded by a large number of cells. The cells in experimental group grew better than the control group.

Key words: biomaterials, material biocompatibility, bone morphogenetic protein-2, injectable calcium sulfate cement, rat bone marrow mesenchymal stem cells, biocompatibility, other grants-supported paper

中图分类号: